Back
Sarepta Therapeutics, Inc. Stock Price Chart
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
30
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$21.11
Seasonality Move:
-4.22%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
Sarepta Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.59 | Sell |
| 20-day SMA: | 21.88 | Sell |
| 50-day SMA: | 21.1 | Buy |
| 200-day SMA: | 25.42 | Sell |
| 8-day EMA: | 4.74 | Buy |
| 20-day EMA: | 2.03 | Buy |
| 50-day EMA: | 0.84 | Buy |
| 200-day EMA: | 0.21 | Buy |
Sarepta Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.7 | Buy |
| Relative Strength Index (14 RSI): | 48.05 | Sell |
| Chaikin Money Flow: | -2047764 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Sarepta Therapeutics, Inc. Technical Analysis
| Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics, Inc. Stock
Is Sarepta Therapeutics, Inc. Stock a Buy?
-
Sarepta Therapeutics, Inc. share price is 21.31 while SRPT 8-day simple moving average is 21.59, which is a Sell signal.
-
The stock price of SRPT is 21.31 while Sarepta Therapeutics, Inc. 20-day SMA is 21.88, which makes it a Sell.
-
Sarepta Therapeutics, Inc. 50-day simple moving average is 21.10 while SRPT share price is 21.31, making it a Buy technically.
-
SRPT stock price is 21.31 and Sarepta Therapeutics, Inc. 200-day simple moving average is 25.42, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
30
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy or a Sell?
-
Sarepta Therapeutics, Inc. stock is rated a SellThe current Sarepta Therapeutics, Inc. [SRPT] share price is $21.31. The Score for SRPT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics, Inc. Stock Info
Market Cap:
2.2B
Price in USD:
21.31
Share Volume:
2.3M
Sarepta Therapeutics, Inc. 52-Week Range
52-Week High:
120.05
52-Week Low:
10.42
Sell
30
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Sarepta Therapeutics, Inc. Share Price Forecast
-
What is the Sarepta Therapeutics, Inc. stock price today?The Sarepta Therapeutics, Inc. stock price is 21.31 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics, Inc. is overvalued.
Is Sarepta Therapeutics, Inc. Stock a Buy?
-
Sarepta Therapeutics, Inc. share price is 21.31 while SRPT 8-day exponential moving average is 4.74, which is a Buy signal.
-
The stock price of SRPT is 21.31 while Sarepta Therapeutics, Inc. 20-day EMA is 2.03, which makes it a Buy.
-
Sarepta Therapeutics, Inc. 50-day exponential moving average is 0.84 while SRPT share price is 21.31, making it a Buy technically.
-
SRPT stock price is 21.31 and Sarepta Therapeutics, Inc. 200-day simple moving average is 0.21, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics, Inc.
Is Sarepta Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.50 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.12 per share, and an increase next year of $0.33 per share.
Technical Analysis of Sarepta Therapeutics, Inc.
Should I short Sarepta Therapeutics, Inc. stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is 1.7, suggesting Sarepta Therapeutics, Inc. is a Buy
-
Sarepta Therapeutics, Inc. Relative Strength Index (RSI) is 48.05, which suggest Sarepta Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Sarepta Therapeutics, Inc. is ( - ), which suggest Sarepta Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Sarepta Therapeutics, Inc. is ( - ), which suggest Sarepta Therapeutics, Inc. is a Buy
* Sarepta Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.